The Global Osteoarthritis Market Size Historical Growth, Analysis, Opportunities and Forecast To 2025
The Global Osteoarthritis Market Size is majorly driven by factors such as prevalence of osteoarthritis in the geriatric population, and rising need and demand for proper treatment of osteoarthritis across the globe.
(EMAILWIRE.COM, September 18, 2018 ) Global Osteoarthritis Market major player include: Pfizer AG, Novartis AG, Johnson & Johnson Inc., GlaxoSmithKline plc.
Osteoarthritis is considered to be the most common type of arthritis, affecting millions of people globally. It can be defined as a disorder that affects mostly the joints in a human body, and is caused by the inflammation, breakdown, and loss of cartilage in the joints of hand, knees, spine, and hip. This is also termed as degenerative arthritis. The major prevalence of this disorder is found in the geriatric population. Osteoarthritis on an average affects 10% of men and 12% of women that are aged above 60 years. It is a progressive disease that has no permanent cure, but its pain and swelling can be controlled with the help of pain killers that helps an individual to stay mobile and carry out regular activities.
Request for Sample of This Research Report @ https://bit.ly/2xncJDN
Osteoarthritis normally begins after the age of 40 years, but can affect the younger people after traumatic injury. This is a chronic degenerative disorder that results in biochemical breakdown of the cartilages in the synovial joints. The wear and tear of the tissues over the time is one of the major cause of osteoarthritis. This disorder is majorly characterised by pain, stiffness, loss of flexibility, tenderness, and bone spurs. With no proper cure to this disorder the major painkillers are used for reducing the intensity of pain caused due to this disorder. Moreover, staying active by maintaining healthy weight by regular exercising and stretching may slow down the progression of this disorder and help in improving the pain and joint function. While, continuous increase in the number of phase III drugs such as Invossa, and Ampion would also influence the market in the near future.
Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/global-osteoarthritis-market/inquire-before-buying
The market is primarily driven by growing number of patients suffering from osteoarthritis globally. For instance, approximately 27 million people in the U.S. alone which is one of the major reason that has increased disability in the U.S. Additionally, increased number of chronic disorder such as diabetes, & cardiovascular diseases, and increasing preference for the sedentary lifestyle that reduces the movement of the body would add on the growth of this market during the forecast period. Moreover, rising prevalence of geriatric population would also spur the market in the near future. According to National Institute of Health, the aging population is projected to increase by 17% (1.6 billion) total population by 2050.
Browse Full Report @ https://www.polarismarketresearch.com/industry-analysis/global-osteoarthritis-market/
Osteoarthritis is considered to be the most common type of arthritis, affecting millions of people globally. It can be defined as a disorder that affects mostly the joints in a human body, and is caused by the inflammation, breakdown, and loss of cartilage in the joints of hand, knees, spine, and hip. This is also termed as degenerative arthritis. The major prevalence of this disorder is found in the geriatric population. Osteoarthritis on an average affects 10% of men and 12% of women that are aged above 60 years. It is a progressive disease that has no permanent cure, but its pain and swelling can be controlled with the help of pain killers that helps an individual to stay mobile and carry out regular activities.
Request for Sample of This Research Report @ https://bit.ly/2xncJDN
Osteoarthritis normally begins after the age of 40 years, but can affect the younger people after traumatic injury. This is a chronic degenerative disorder that results in biochemical breakdown of the cartilages in the synovial joints. The wear and tear of the tissues over the time is one of the major cause of osteoarthritis. This disorder is majorly characterised by pain, stiffness, loss of flexibility, tenderness, and bone spurs. With no proper cure to this disorder the major painkillers are used for reducing the intensity of pain caused due to this disorder. Moreover, staying active by maintaining healthy weight by regular exercising and stretching may slow down the progression of this disorder and help in improving the pain and joint function. While, continuous increase in the number of phase III drugs such as Invossa, and Ampion would also influence the market in the near future.
Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/global-osteoarthritis-market/inquire-before-buying
The market is primarily driven by growing number of patients suffering from osteoarthritis globally. For instance, approximately 27 million people in the U.S. alone which is one of the major reason that has increased disability in the U.S. Additionally, increased number of chronic disorder such as diabetes, & cardiovascular diseases, and increasing preference for the sedentary lifestyle that reduces the movement of the body would add on the growth of this market during the forecast period. Moreover, rising prevalence of geriatric population would also spur the market in the near future. According to National Institute of Health, the aging population is projected to increase by 17% (1.6 billion) total population by 2050.
Browse Full Report @ https://www.polarismarketresearch.com/industry-analysis/global-osteoarthritis-market/
Contact Information:
Polaris Market Research
Neel
Tel: +1-646-568-9980
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Polaris Market Research
Neel
Tel: +1-646-568-9980
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results